Biomedical
Maria Kantzanou,
Evangelos Kostares,
Georgia Kostare,
Evangelia Papagiannopoulou,
Michael Kostares,
Our study seeks to provide a comprehensive assessment of leishmaniasis prevalence among blood donors, employing rigorous methodologies to inform public health initiatives and transfusion safety measures. A thorough literature search was conducted using electronic databases (Medline, Scopus, Web of Science, and Google Scholar) to identify the relevant studies reporting the prevalence of leishmaniasis among blood donors, gathering a wide range of studies encompassing different geographic locations and time periods. The pooled prevalence with a 95% confidence interval (CI) was estimated, and quality assessment, outlier analysis, and influential analysis were performed to ensure the robustness and validity of the findings. Our search and subsequent analyses led to the inclusion of thirty-five studies in our review. Using molecular diagnostic methods, the prevalence was estimated at 2.3% (95% CI 1–3.9%), while serological diagnostic methods indicated a higher prevalence rate of 4.5% (95% CI 2.8–6.7%). Notably, we observed significant heterogeneity among the included studies for each analysis. The observed heterogeneity highlights the need for future research to delve into the factors influencing leishmaniasis prevalence, with prospective and retrospective studies addressing the limitations identified in this review.
Show by month | Manuscript | Video Summary |
---|---|---|
2024 November | 31 | 31 |
2024 October | 42 | 42 |
Total | 73 | 73 |
Show by month | Manuscript | Video Summary |
---|---|---|
2024 November | 31 | 31 |
2024 October | 42 | 42 |
Total | 73 | 73 |